{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:40:05Z","timestamp":1780548005031,"version":"3.54.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12964-017-0204-z","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T11:59:47Z","timestamp":1510660787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities"],"prefix":"10.1186","volume":"15","author":[{"given":"Nguyet","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awanit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simi","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"204_CR1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0002-9440(10)64757-8","volume":"156","author":"P Auvinen","year":"2000","unstructured":"Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol. 2000;156:529\u201336.","journal-title":"Am J Pathol"},{"key":"204_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-013-2804-7","volume":"143","author":"P Auvinen","year":"2014","unstructured":"Auvinen P, Rilla K, Tumelius R, Tammi M, Sironen R, Soini Y, Kosma VM, Mannermaa A, Viikari J, Tammi R. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival. Breast Cancer Res Treat. 2014;143:277\u201386.","journal-title":"Breast Cancer Res Treat"},{"key":"204_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2015.00043","volume":"6","author":"H Siiskonen","year":"2015","unstructured":"Siiskonen H, Oikari S, Pasonen-Seppanen S, Rilla K. Hyaluronan synthase 1: a mysterious enzyme with unexpected functions. Front Immunol. 2015;6:43.","journal-title":"Front Immunol"},{"key":"204_CR4","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1074\/jbc.R100037200","volume":"277","author":"MI Tammi","year":"2002","unstructured":"Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002;277:4581\u20134.","journal-title":"J Biol Chem"},{"key":"204_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.MP.0000051582.75890.2D","volume":"16","author":"M Wernicke","year":"2003","unstructured":"Wernicke M, Pineiro LC, Caramutti D, Dorn VG, Raffo MM, Guixa HG, Telenta M, Morandi AA. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol. 2003;16:99\u2013107.","journal-title":"Mod Pathol"},{"key":"204_CR6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7863\/jum.2002.21.5.531","volume":"21","author":"P Vignal","year":"2002","unstructured":"Vignal P, Meslet MR, Romeo JM, Feuilhade F. Sonographic morphology of infiltrating breast carcinoma: relationship with the shape of the hyaluronan extracellular matrix. J Ultrasound Med. 2002;21:532\u20138.","journal-title":"J Ultrasound Med"},{"key":"204_CR7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ijc.2910460309","volume":"46","author":"B Delpech","year":"1990","unstructured":"Delpech B, Chevallier B, Reinhardt N, Julien JP, Duval C, Maingonnat C, Bastit P, Asselain B. Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer. 1990;46:388\u201390.","journal-title":"Int J Cancer"},{"key":"204_CR8","doi-asserted-by":"crossref","first-page":"10233","DOI":"10.1158\/0008-5472.CAN-06-1464","volume":"66","author":"M Gotte","year":"2006","unstructured":"Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 2006;66:10233\u20137.","journal-title":"Cancer Res"},{"key":"204_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568006053005056","volume":"5","author":"S Adamia","year":"2005","unstructured":"Adamia S, Maxwell CA, Pilarski LM. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:3\u201314.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"204_CR10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2353\/ajpath.2009.080501","volume":"174","author":"AG Bharadwaj","year":"2009","unstructured":"Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, Simpson MA. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol. 2009;174:1027\u201336.","journal-title":"Am J Pathol"},{"key":"204_CR11","doi-asserted-by":"crossref","first-page":"817613","DOI":"10.1155\/2014\/817613","volume":"2014","author":"A Kultti","year":"2014","unstructured":"Kultti A, Zhao C, Singha NC, Zimmerman S, Osgood RJ, Symons R, Jiang P, Li X, Thompson CB, Infante JR, et al. Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. Biomed Res Int. 2014;2014:817613.","journal-title":"Biomed Res Int"},{"key":"204_CR12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1039\/c0ib00096e","volume":"3","author":"M Veiseh","year":"2011","unstructured":"Veiseh M, Turley EA. Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer. Integr Biol (Camb). 2011;3:304\u201315.","journal-title":"Integr Biol (Camb)"},{"key":"204_CR13","doi-asserted-by":"crossref","first-page":"18840","DOI":"10.1074\/jbc.M109.013813","volume":"284","author":"A Ghosh","year":"2009","unstructured":"Ghosh A, Kuppusamy H, Pilarski LM. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer. J Biol Chem. 2009;284:18840\u201350.","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"204_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/eci.12361","volume":"45","author":"KK Nordgren","year":"2015","unstructured":"Nordgren KK, Skildum AJ. The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer. Eur J Clin Investig. 2015;45(Suppl 1):9\u201315.","journal-title":"Eur J Clin Investig"},{"key":"204_CR15","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2008-02-141770","volume":"112","author":"S Adamia","year":"2008","unstructured":"Adamia S, Reichert AA, Kuppusamy H, Kriangkum J, Ghosh A, Hodges JJ, Pilarski PM, Treon SP, Mant MJ, Reiman T, et al. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. Blood. 2008;112:5111\u201321.","journal-title":"Blood"},{"key":"204_CR16","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/cncr.26520","volume":"118","author":"A Chi","year":"2012","unstructured":"Chi A, Shirodkar SP, Escudero DO, Ekwenna OO, Yates TJ, Ayyathurai R, Garcia-Roig M, Gahan JC, Manoharan M, Bird VG, Lokeshwar VB. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis. Cancer. 2012;118:2394\u2013402.","journal-title":"Cancer"},{"key":"204_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:CLIN.0000017203.71293.e0","volume":"21","author":"Y Yamada","year":"2004","unstructured":"Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S, Ochiai A, Ueda M, Kimata K. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis. 2004;21:57\u201363.","journal-title":"Clin Exp Metastasis"},{"key":"204_CR18","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2004-10-3825","volume":"105","author":"S Adamia","year":"2005","unstructured":"Adamia S, Reiman T, Crainie M, Mant MJ, Belch AR, Pilarski LM. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood. 2005;105:4836\u201344.","journal-title":"Blood"},{"key":"204_CR19","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/cncr.25565","volume":"117","author":"MW Kramer","year":"2011","unstructured":"Kramer MW, Escudero DO, Lokeshwar SD, Golshani R, Ekwenna OO, Acosta K, Merseburger AS, Soloway M, Lokeshwar VB. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer. 2011;117:1197\u2013209.","journal-title":"Cancer"},{"key":"204_CR20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00428-004-1197-8","volume":"446","author":"N Kanomata","year":"2005","unstructured":"Kanomata N, Yokose T, Kamijo T, Yonou H, Hasebe T, Itano N, Kimata K, Ochiai A. Hyaluronan synthase expression in pleural malignant mesotheliomas. Virchows Arch. 2005;446:246\u201350.","journal-title":"Virchows Arch"},{"key":"204_CR21","doi-asserted-by":"crossref","first-page":"739150","DOI":"10.1155\/2011\/739150","volume":"2011","author":"H Yabushita","year":"2011","unstructured":"Yabushita H, Iwasaki K, Kanyama K, Obayashi Y, Zhuo L, Itano N, Kimata K, Wakatsuki A. Clinicopathological role of serum-derived Hyaluronan-associated protein (SHAP)-Hyaluronan complex in endometrial cancer. Obstet Gynecol Int. 2011;2011:739150.","journal-title":"Obstet Gynecol Int"},{"key":"204_CR22","first-page":"739","volume":"12","author":"H Yabushita","year":"2004","unstructured":"Yabushita H, Noguchi M, Kishida T, Fusano K, Noguchi Y, Itano N, Kimata K, Noguchi M. Hyaluronan synthase expression in ovarian cancer. Oncol Rep. 2004;12:739\u201343.","journal-title":"Oncol Rep"},{"key":"204_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/sonc.2003.50042","volume":"30","author":"S Adamia","year":"2003","unstructured":"Adamia S, Crainie M, Kriangkum J, Mant MJ, Belch AR, Pilarski LM. Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia. Semin Oncol. 2003;30:165\u20138.","journal-title":"Semin Oncol"},{"key":"204_CR24","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","volume":"121","author":"LL Marotta","year":"2011","unstructured":"Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, Bloushtain-Qimron N, Kim JJ, Choudhury SA, Maruyama R, et al. The JAK2\/STAT3 signaling pathway is required for growth of CD44(+)CD24(\u2212) stem cell-like breast cancer cells in human tumors. J Clin Invest. 2011;121:2723\u201335.","journal-title":"J Clin Invest"},{"key":"204_CR25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccr.2007.01.013","volume":"11","author":"M Shipitsin","year":"2007","unstructured":"Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007;11:259\u201373.","journal-title":"Cancer Cell"},{"key":"204_CR26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/CCO.0b013e32834bf8ae","volume":"23","author":"S Irshad","year":"2011","unstructured":"Irshad S, Ellis P, Tutt A. Molecular heterogeneity of triple-negative breast cancer and its clinical implications. Curr Opin Oncol. 2011;23:566\u201377.","journal-title":"Curr Opin Oncol"},{"key":"204_CR27","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jcb.22781","volume":"111","author":"RA Burrell","year":"2010","unstructured":"Burrell RA, Juul N, Johnston SR, Reis-Filho JS, Szallasi Z, Swanton C. Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer. J Cell Biochem. 2010;111:782\u201390.","journal-title":"J Cell Biochem"},{"key":"204_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","volume":"12","author":"A Marusyk","year":"2012","unstructured":"Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012;12:323\u201334.","journal-title":"Nat Rev Cancer"},{"key":"204_CR29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1210\/me.2011-1302","volume":"26","author":"SC Baumgarten","year":"2012","unstructured":"Baumgarten SC, Frasor J. Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol. 2012;26:360\u201371.","journal-title":"Mol Endocrinol"},{"key":"204_CR30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fonc.2014.00366","volume":"4","author":"MJ Gerdes","year":"2014","unstructured":"Gerdes MJ, Sood A, Sevinsky C, Pris AD, Zavodszky MI, Ginty F. Emerging understanding of multiscale tumor heterogeneity. Front Oncol. 2014;4:366.","journal-title":"Front Oncol"},{"key":"204_CR31","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/ijbs.7.1122","volume":"7","author":"JY Chan","year":"2011","unstructured":"Chan JY. A clinical overview of centrosome amplification in human cancers. Int J Biol Sci. 2011;7:1122\u201344.","journal-title":"Int J Biol Sci"},{"key":"204_CR32","first-page":"219","volume":"36","author":"BI Gerashchenko","year":"2014","unstructured":"Gerashchenko BI, Huna A, Erenpreisa J. Characterization of breast cancer DNA content profiles as a prognostic tool. Exp Oncol. 2014;36:219\u201325.","journal-title":"Exp Oncol"},{"key":"204_CR33","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.humpath.2010.12.027","volume":"42","author":"Y Gao","year":"2011","unstructured":"Gao Y, Niu Y, Wang X, Wei L, Zhang R, Lv S, Yu Q, Yang X. Chromosome aberrations associated with centrosome defects: a study of comparative genomic hybridization in breast cancer. Hum Pathol. 2011;42:1693\u2013701.","journal-title":"Hum Pathol"},{"key":"204_CR34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12026-014-8582-4","volume":"60","author":"MC Maroun","year":"2014","unstructured":"Maroun MC, Olivero O, Lipovich L, Stark A, Tait L, Bandyopadhyay S, Burke M, Zarbo R, Chitale D, David Nathanson S, et al. Anti-centrosome antibodies in breast cancer are the expression of autoimmunity. Immunol Res. 2014;60:339\u201347.","journal-title":"Immunol Res"},{"key":"204_CR35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0970-9371.97150","volume":"29","author":"RA Sakr","year":"2012","unstructured":"Sakr RA, Fleury J, Prengel C, Bernaudin JF, Uzan S, Rouzier R, Darai E. Can the centrosome be a marker for DNA ploidy in breast cancer? J Cytol. 2012;29:111\u20135.","journal-title":"J Cytol"},{"key":"204_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338\u201345.","journal-title":"Nature"},{"key":"204_CR37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-61779-182-6_10","volume":"761","author":"HT Ma","year":"2011","unstructured":"Ma HT, Poon RY. Synchronization of HeLa cells. Methods Mol Biol. 2011;761:151\u201361.","journal-title":"Methods Mol Biol"},{"key":"204_CR38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/ijmm.2015.2222","volume":"36","author":"L Li","year":"2015","unstructured":"Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, Sun B, Zhang B, Cao W. Transforming growth factor-beta1 induces EMT by the transactivation of epidermal growth factor signaling through HA\/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113\u201322.","journal-title":"Int J Mol Med"},{"key":"204_CR39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-07-2140","volume":"68","author":"R Golshani","year":"2008","unstructured":"Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res. 2008;68:483\u201391.","journal-title":"Cancer Res"},{"key":"204_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","volume":"6","author":"S Misra","year":"2015","unstructured":"Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between Hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol. 2015;6:201.","journal-title":"Front Immunol"},{"key":"204_CR41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","volume":"4","author":"Y Yan","year":"2015","unstructured":"Yan Y, Zuo X, Wei D. Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl Med. 2015;4:1033\u201343.","journal-title":"Stem Cells Transl Med"},{"key":"204_CR42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1242\/jcs.022038","volume":"121","author":"CA Maxwell","year":"2008","unstructured":"Maxwell CA, McCarthy J, Turley E. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci. 2008;121:925\u201332.","journal-title":"J Cell Sci"},{"key":"204_CR43","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/1940-6207.CAPR-10-0234","volume":"3","author":"F Michor","year":"2010","unstructured":"Michor F, Polyak K. The origins and implications of intratumor heterogeneity. Cancer Prev Res (Phila). 2010;3:1361\u20134.","journal-title":"Cancer Prev Res (Phila)"},{"key":"204_CR44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/apm.12033","volume":"121","author":"A Bhatia","year":"2013","unstructured":"Bhatia A, Kumar Y. Cancer cell micronucleus: an update on clinical and diagnostic applications. APMIS. 2013;121:569\u201381.","journal-title":"APMIS"},{"key":"204_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13008-015-0009-7","volume":"10","author":"M Giam","year":"2015","unstructured":"Giam M, Rancati G. Aneuploidy and chromosomal instability in cancer: a jackpot to chaos. Cell Div. 2015;10:3.","journal-title":"Cell Div"},{"key":"204_CR46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/1044549041562276","volume":"23","author":"Q Wang","year":"2004","unstructured":"Wang Q, Hirohashi Y, Furuuchi K, Zhao H, Liu Q, Zhang H, Murali R, Berezov A, Du X, Li B, Greene MI. The centrosome in normal and transformed cells. DNA Cell Biol. 2004;23:475\u201389.","journal-title":"DNA Cell Biol"},{"key":"204_CR47","doi-asserted-by":"crossref","unstructured":"Godinho SA, Pellman D. Causes and consequences of centrosome abnormalities in cancer. Philos Trans R Soc Lond Ser B Biol Sci. 2014;369","DOI":"10.1098\/rstb.2013.0467"},{"key":"204_CR48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2402454","volume":"16","author":"A Kramer","year":"2002","unstructured":"Kramer A, Neben K, Ho AD. Centrosome replication, genomic instability and cancer. Leukemia. 2002;16:767\u201375.","journal-title":"Leukemia"},{"key":"204_CR49","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/bjc.2011.567","volume":"106","author":"F Cardinale","year":"2011","unstructured":"Cardinale F, Bruzzi P, Bolognesi C. Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis. Br J Cancer. 2011;106:780\u201390.","journal-title":"Br J Cancer"},{"key":"204_CR50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cyt.12096","volume":"25","author":"S Verma","year":"2014","unstructured":"Verma S, Dey P. Correlation of morphological markers of chromosomal instability in fine needle aspiration cytology with grade of breast cancer. Cytopathology. 2014;25:259\u201363.","journal-title":"Cytopathology"},{"key":"204_CR51","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/ng.2007.2","volume":"39","author":"MA Pujana","year":"2007","unstructured":"Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet. 2007;39:1338\u201349.","journal-title":"Nat Genet"},{"key":"204_CR52","first-page":"567","volume":"4","author":"C Wang","year":"1998","unstructured":"Wang C, Thor AD, Moore DH 2nd, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res. 1998;4:567\u201376.","journal-title":"Clin Cancer Res"},{"key":"204_CR53","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.3892\/ol.2015.3773","volume":"10","author":"X He","year":"2015","unstructured":"He X, Liao W, Li Y, Wang Y, Chen Q, Jin J, He S. Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival. Oncol Lett. 2015;10:3639\u201346.","journal-title":"Oncol Lett"},{"key":"204_CR54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7150\/jca.12990","volume":"6","author":"XB Cheng","year":"2015","unstructured":"Cheng XB, Sato N, Kohi S, Koga A, Hirata K. Receptor for Hyaluronic acid-mediated motility is associated with poor survival in pancreatic Ductal Adenocarcinoma. J Cancer. 2015;6:1093\u20138.","journal-title":"J Cancer"},{"key":"204_CR55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.941","volume":"195","author":"V Assmann","year":"2001","unstructured":"Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR, Hanby AM. The pattern of expression of the microtubule-binding protein RHAMM\/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J Pathol. 2001;195:191\u20136.","journal-title":"J Pathol"},{"key":"204_CR56","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1073\/pnas.1319190110","volume":"111","author":"Z Wang","year":"2014","unstructured":"Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X, Zhang X, Zhang F, Chen H, Liu Y, et al. Interplay of mevalonate and hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc Natl Acad Sci U S A. 2014;111:E89\u201398.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"204_CR57","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.4161\/cc.29270","volume":"13","author":"H Chen","year":"2014","unstructured":"Chen H, Mohan P, Jiang J, Nemirovsky O, He D, Fleisch MC, Niederacher D, Pilarski LM, Lim CJ, Maxwell CA. Spatial regulation of aurora a activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2. Cell Cycle. 2014;13:2248\u201361.","journal-title":"Cell Cycle"},{"key":"204_CR58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/j.1460-2075.1994.tb06261.x","volume":"13","author":"B Yang","year":"1994","unstructured":"Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 1994;13:286\u201396.","journal-title":"EMBO J"},{"key":"204_CR59","doi-asserted-by":"crossref","first-page":"e1001199","DOI":"10.1371\/journal.pbio.1001199","volume":"9","author":"CA Maxwell","year":"2011","unstructured":"Maxwell CA, Benitez J, Gomez-Baldo L, Osorio A, Bonifaci N, Fernandez-Ramires R, Costes SV, Guino E, Chen H, Evans GJ, et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol. 2011;9:e1001199.","journal-title":"PLoS Biol"},{"key":"204_CR60","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.4161\/cc.21396","volume":"11","author":"P Tarapore","year":"2012","unstructured":"Tarapore P, Hanashiro K, Fukasawa K. Analysis of centrosome localization of BRCA1 and its activity in suppressing centrosomal aster formation. Cell Cycle. 2012;11:2931\u201346.","journal-title":"Cell Cycle"},{"key":"204_CR61","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1369\/jhc.3A6221.2004","volume":"52","author":"H Zhang","year":"2004","unstructured":"Zhang H, Baader SL, Sixt M, Kappler J, Rauch U. Neurocan-GFP fusion protein: a new approach to detect hyaluronan on tissue sections and living cells. J Histochem Cytochem. 2004;52:915\u201322.","journal-title":"J Histochem Cytochem"},{"key":"204_CR62","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1074\/jbc.M112.443879","volume":"288","author":"K Rilla","year":"2013","unstructured":"Rilla K, Oikari S, Jokela TA, Hyttinen JM, Karna R, Tammi RH, Tammi MI. Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. J Biol Chem. 2013;288:5973\u201383.","journal-title":"J Biol Chem"},{"key":"204_CR63","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1074\/jbc.273.4.1923","volume":"273","author":"AP Spicer","year":"1998","unstructured":"Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem. 1998;273:1923\u201332.","journal-title":"J Biol Chem"},{"key":"204_CR64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/art.24302","volume":"60","author":"M David-Raoudi","year":"2009","unstructured":"David-Raoudi M, Deschrevel B, Leclercq S, Galera P, Boumediene K, Pujol JP. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: role of p38 and Akt. Arthritis Rheum. 2009;60:760\u201370.","journal-title":"Arthritis Rheum"},{"key":"204_CR65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yexcr.2013.09.021","volume":"320","author":"H Siiskonen","year":"2014","unstructured":"Siiskonen H, Karna R, Hyttinen JM, Tammi RH, Tammi MI, Rilla K. Hyaluronan synthase 1 (HAS1) produces a cytokine-and glucose-inducible, CD44-dependent cell surface coat. Exp Cell Res. 2014;320:153\u201363.","journal-title":"Exp Cell Res"},{"key":"204_CR66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00418-013-1143-4","volume":"141","author":"K Torronen","year":"2014","unstructured":"Torronen K, Nikunen K, Karna R, Tammi M, Tammi R, Rilla K. Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. Histochem Cell Biol. 2014;141:17\u201331.","journal-title":"Histochem Cell Biol"},{"key":"204_CR67","doi-asserted-by":"crossref","first-page":"25085","DOI":"10.1074\/jbc.274.35.25085","volume":"274","author":"N Itano","year":"1999","unstructured":"Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999;274:25085\u201392.","journal-title":"J Biol Chem"},{"key":"204_CR68","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/onc.2012.475","volume":"32","author":"H Porsch","year":"2013","unstructured":"Porsch H, Bernert B, Mehic M, Theocharis AD, Heldin CH, Heldin P. Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene. 2013;32:4355\u201365.","journal-title":"Oncogene"},{"key":"204_CR69","doi-asserted-by":"crossref","first-page":"45801","DOI":"10.1074\/jbc.M308168200","volume":"278","author":"A Zoltan-Jones","year":"2003","unstructured":"Zoltan-Jones A, Huang L, Ghatak S, Toole BP. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem. 2003;278:45801\u201310.","journal-title":"J Biol Chem"},{"key":"204_CR70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/mutage\/geq052","volume":"26","author":"M Fenech","year":"2011","unstructured":"Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD, Thomas P. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. 2011;26:125\u201332.","journal-title":"Mutagenesis"},{"key":"204_CR71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fonc.2013.00277","volume":"3","author":"GA Pihan","year":"2013","unstructured":"Pihan GA. Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer. Front Oncol. 2013;3:277.","journal-title":"Front Oncol"},{"key":"204_CR72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10555-012-9413-5","volume":"32","author":"A Ogden","year":"2013","unstructured":"Ogden A, Rida PC, Aneja R. Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration. Cancer Metastasis Rev. 2013;32:269\u201387.","journal-title":"Cancer Metastasis Rev"},{"key":"204_CR73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10555-013-9436-6","volume":"32","author":"TA Potapova","year":"2013","unstructured":"Potapova TA, Zhu J, Li R. Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev. 2013;32:377\u201389.","journal-title":"Cancer Metastasis Rev"},{"key":"204_CR74","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2003-11-4079","volume":"104","author":"CA Maxwell","year":"2004","unstructured":"Maxwell CA, Rasmussen E, Zhan F, Keats JJ, Adamia S, Strachan E, Crainie M, Walker R, Belch AR, Pilarski LM, et al. RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma. Blood. 2004;104:1151\u20138.","journal-title":"Blood"},{"key":"204_CR75","doi-asserted-by":"crossref","first-page":"e0120020","DOI":"10.1371\/journal.pone.0120020","volume":"10","author":"I Blanco","year":"2015","unstructured":"Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sanchez-Gracia A, Rozas J, Bonifaci N, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1\/2 mutation carriers. PLoS One. 2015;10:e0120020.","journal-title":"PLoS One"},{"key":"204_CR76","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1369\/jhc.4A6356.2004","volume":"52","author":"SP Evanko","year":"2004","unstructured":"Evanko SP, Parks WT, Wight TN. Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle. J Histochem Cytochem. 2004;52:1525\u201335.","journal-title":"J Histochem Cytochem"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-017-0204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T03:48:33Z","timestamp":1570333713000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-017-0204-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/s12964-017-0204-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"article-number":"48"}}